AAAAAA

   
Results: 1-14 |
Results: 14
Dacarbazine (Deticene (R))
Authors: D'Incan, M Souteyrand, P
Citation: M. D'Incan et P. Souteyrand, Dacarbazine (Deticene (R)), ANN DER VEN, 128(4), 2001, pp. 517-525
Scleromyxedema: complete response to extracorporeal photopheresis and steroids.
Authors: D'Incan, M Franck, F Kanold, J Bacin, F Achin, R Beyvin, AJ Demeocq, F Souteyrand, P
Citation: M. D'Incan et al., Scleromyxedema: complete response to extracorporeal photopheresis and steroids., ANN DER VEN, 128(1), 2001, pp. 38-41
Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate
Authors: Tournadre, A D'Incan, M Dubost, JJ Franck, F Dechelotte, P Souteyrand, P Soubrier, M
Citation: A. Tournadre et al., Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate, MAYO CLIN P, 76(8), 2001, pp. 845-848
Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases.
Authors: D'Incan, M Kanold, J Halle, P De Lumley, L Souteyrand, P Demeocq, F
Citation: M. D'Incan et al., Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases., ANN DER VEN, 127(2), 2000, pp. 166-170
Delays in diagnosis and melanoma prognosis (I): The role of patients
Authors: Richard, MA Grob, JJ Avril, MF Delaunay, M Gouvernet, J Wolkenstein, P Souteyrand, P Dreno, B Bonerandi, JJ Dalac, S Machet, L Guillaume, JC Chevrant-Breton, J Vilmer, C Aubin, F Guillot, B Beylot-Barry, M Lok, C Raison-Peyron, N Chemaly, P
Citation: Ma. Richard et al., Delays in diagnosis and melanoma prognosis (I): The role of patients, INT J CANC, 89(3), 2000, pp. 271-279
Delays in diagnosis and melanoma prognosis (II): The role of doctors
Authors: Richard, MA Grob, JJ Avril, MF Delaunay, M Gouvernet, J Wolkenstein, P Souteyrand, P Dreno, B Bonerandi, JJ Dalac, S Machet, L Guillaume, JC Chevrant-Breton, J Vilmer, C Aubin, F Guillot, B Beylot-Barry, M Lok, C Raison-Peyron, N Chemaly, P
Citation: Ma. Richard et al., Delays in diagnosis and melanoma prognosis (II): The role of doctors, INT J CANC, 89(3), 2000, pp. 280-285
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases
Authors: Vergier, B de Muret, A Beylot-Barry, M Vaillant, L Ekouevi, D Chene, G Carlotti, A Franck, N Dechelotte, P Souteyrand, P Courville, P Joly, P Delaunay, M Bagot, M Grange, F Fraitag, S Bosq, J Petrella, T Durlach, A De Mascarel, A Merlio, JP Wechsler, J
Citation: B. Vergier et al., Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases, BLOOD, 95(7), 2000, pp. 2212-2218
Acquired angioedema with C1 inhibitor deficiency: Is the distinction between type I and type II still relevant?
Authors: D'Incan, M Tridon, A Ponard, D Dumestre-Perard, C Ferrier-Le Bouedec, MC Betail, G Souteyrand, P Caillaud, D
Citation: M. D'Incan et al., Acquired angioedema with C1 inhibitor deficiency: Is the distinction between type I and type II still relevant?, DERMATOLOGY, 199(3), 1999, pp. 227-230
Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group
Authors: Cure, H Souteyrand, P Ouabdesselam, R Roche, H Ravaud, A D'incan, M Viens, P Fargeot, P Lentz, MA Fumoleau, P Hanauske, A Chollet, P
Citation: H. Cure et al., Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group, MELANOMA RE, 9(6), 1999, pp. 607-610
The spectrum of cutaneous lymphomas in HIV infection - A study of 21 cases
Authors: Beylot-Barry, M Vergier, B Masquelier, B Bagot, M Joly, P Souteyrand, P Vaillant, L Avril, MF Franck, N Fraitag, S Delaunay, M Laroche, L Esteve, E Courville, P Dechelotte, P Beylot, C De Mascarel, A Wechsler, J Merlio, JP
Citation: M. Beylot-barry et al., The spectrum of cutaneous lymphomas in HIV infection - A study of 21 cases, AM J SURG P, 23(10), 1999, pp. 1208-1216
Pseudoepitheliomatous hyperplasia in cutaneous T-cell lymphoma. A clinical, histopathological and immunohistochemical study with particular interest in epithelial growth factor expression
Authors: Courville, P Wechsler, J Thomine, E Vergier, B Fonck, Y Souteyrand, P Beylot-Barry, M Bagot, M Joly, P
Citation: P. Courville et al., Pseudoepitheliomatous hyperplasia in cutaneous T-cell lymphoma. A clinical, histopathological and immunohistochemical study with particular interest in epithelial growth factor expression, BR J DERM, 140(3), 1999, pp. 421-426
Melanoma and tumor thickness - Challenges of early diagnosis
Authors: Richard, MA Grob, JJ Avril, MF Delaunay, M Thirion, X Wolkenstein, P Souteyrand, P Dreno, B Bonerandi, JJ Dalac, S Machet, L Guillaume, JC Chevrant-Breton, J Vilmer, C Aubin, F Guillot, B Beylot-Barry, M Lok, C Raison-Peyron, N Chemaly, P
Citation: Ma. Richard et al., Melanoma and tumor thickness - Challenges of early diagnosis, ARCH DERMAT, 135(3), 1999, pp. 269-274
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas
Authors: Esteve, E Bagot, M Joly, P Souteyrand, P Beylot-Barry, M Vaillant, L Delaunay, M Avril, MF Laroche, L Grange, F Thomine, E Wechsler, J
Citation: E. Esteve et al., A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas, ARCH DERMAT, 135(11), 1999, pp. 1349-1353
Cutaneous lymphomas
Authors: Souteyrand, P Fabricio, L d'Incan, M
Citation: P. Souteyrand et al., Cutaneous lymphomas, EJD BOOK S, 1998, pp. 145-149
Risultati: 1-14 |